Making Menopause Support Real: What Employers Are Asking and How We Help
Menopause affects retention, productivity, and healthcare costs. Learn why employers are making menopause support a core benefits strategy.
Menopause Is a Workforce Issue. Your Pharmacy Benefit Should Treat It That Way.
Menopause affects productivity, retention, and healthcare costs. Learn why pharmacy benefit design is central to effective menopause support.
Menopause Benefits: From Nice-to-Have to Business Imperative
Menopause affects retention, productivity, and healthcare costs. Learn why employers are making menopause support a core benefits strategy.
Why “Affordability” Became the Word of the Moment — and What Healthcare Misses
Healthcare affordability is not just about price. Learn what patients experience at the pharmacy counter and why unpredictability erodes trust.
The Difference Between Access on Paper and Access in Practice
Understand why specialty drug access breaks down after coverage is approved and how employers can close the gap between coverage and care.
Behind Every Claim Is a Person: Why Prescription Care Needs a Different Playbook in 2026
If you spend your days looking at pharmacy trend reports and renewal spreadsheets, it is easy to forget what those numbers really represent.
The Hidden Driver of Employee Experience (and Retention): Human-Led Care Guides
Human-led Care Guides reduce friction in complex medication moments, helping employees start and stay on therapy. The result: better experience, higher confidence, and stronger retention for employers.
The Yardstick That Matters: Redefining Outcomes in Prescription Care
Outcomes don’t improve by accident. Better processes, faster therapy access, and clear guidance are the foundation of patient-centered prescription care—and the new standard employers should expect.
Formulary design that captures the savings (without disruption)
Rebates don’t equal value. Here’s how to align to net cost, enable substitution, and keep your people on track.
Biosimilars: What HR Leaders Need to Know in 5 Minutes
If we had five minutes between meetings, here’s what I’d share: biosimilars are no longer a maybe. They’re a practical way to protect your budget and keep care steady for your people.